SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-016240
Filing Date
2024-02-22
Accepted
2024-02-22 18:32:25
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 10671
  Complete submission text file 0001213900-24-016240.txt   12098
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address
Reich Kristian (Reporting) CIK: 0001920553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39630 | Film No.: 24666649